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Abstract
Nonsense Mediated Decay (NMD) degrades transcripts that contain a premature STOP codon resulting from
mistranscription or missplicing. However NMD’s surveillance of gene expression varies in efficiency both among and
within human genes. Previous work has shown that the intron content of human genes is influenced by missplicing events
invisible to NMD. Given the high rate of transcriptional errors in eukaryotes, we hypothesized that natural selection has
promoted a dual strategy of ‘‘prevention and cure’’ to alleviate the problem of nonsense transcriptional errors. A prediction
of this hypothesis is that NMD’s inefficiency should leave a signature of ‘‘transcriptional robustness’’ in human gene
sequences that reduces the frequency of nonsense transcriptional errors. For human genes we determined the usage of
‘‘fragile’’ codons, prone to mistranscription into STOP codons, relative to the usage of ‘‘robust’’ codons that do not generate
nonsense errors. We observe that single-exon genes have evolved to become robust to mistranscription, because they show
a significant tendency to avoid fragile codons relative to robust codons when compared to multi-exon genes. A similar
depletion is evident in last exons of multi-exon genes. Histone genes are particularly depleted of fragile codons and thus
highly robust to transcriptional errors. Finally, the protein products of single-exon genes show a strong tendency to avoid
those amino acids that can only be encoded using fragile codons. Each of these observations can be attributed to NMD
deficiency. Thus, in the human genome, wherever the ‘‘cure’’ for nonsense (i.e. NMD) is inefficient, there is increased reliance
on the strategy of nonsense ‘‘prevention’’ (i.e. transcriptional robustness). This study shows that human genes are exposed
to the deleterious influence of transcriptional errors. Moreover, it suggests that gene expression errors are an
underestimated phenomenon, in molecular evolution in general and in selection for genomic robustness in particular.
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Introduction
In mammalian transcripts, premature termination codons
(PTCs) are normally detected by one of two NMD pathways
[1]. The primary, and more efficient, NMD pathway is intron-
dependent and relies on the presence of exon junction complexes
(EJCs) deposited 20-24 nts upstream of the exon-exon junctions
created following splicing of the mRNA (EJC-dependent NMD). A
second, less efficient, intron-independent pathway operates in
mammals and requires the presence of polyA-binding protein
(PABP-dependent NMD). In contrast, in Drosophila melanogaster,
PABP-dependent NMD is the primary pathway in operation since
only a minority of spliced transcripts are under the surveillance of
EJC-dependent NMD [2,3]. The diversity of NMD mechanisms in
eukaryotes is further illustrated among yeast species. In Saccharo-
myces cerevisiae only the intron-independent NMD pathway is
known to operate. Finally, in Schizosaccharomyces pombe, although
intron-dependent NMD is active it is believed to be EJC-
independent [4].
PTCs may arise from heritable nonsense mutations in the
germline or they can be created by transient errors in transcription
and splicing. Previous attention has been paid to splicing errors as
a source of nonsense errors since introns retained in the mature
mRNA can either introduce an intron-encoded PTC or induce a
frameshift leading to the formation of an exon-derived PTC [5].
However, mistranscription is likely to be a significant source of
nonsense errors. Although few direct estimates are available,
assuming a transcriptional error rate of 10
25 errors per nucleotide
[6,7] leads to the estimate that 0.05%-0.5% of transcripts of any
given gene are expected to contain PTCs due to mistranscription
[8]. Moreover, this is a highly conservative estimate since the
single measurement available for a metazoan suggests that the rate
of mistranscription may be as high as 10
23 errors per nucleotide
[9].
The possible consequences of translating PTC-containing
transcripts include loss of functional molecules, dominant negative
interactions and gain-of-function activities. The deleterious effects
of these outcomes are highlighted by the fact that, in mammals,
knockouts of the core effectors of NMD have lethal effects [10].
NMD mitigates the negative effects of PTC-containing
transcripts and hence can be considered as providing a partial
‘‘cure’’ for transcriptional errors. In mammals, the efficiency of
NMD in detecting PTCs varies both among and within genes.
Single-exon genes appear insensitive to NMD [11,12] owing to the
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dependent pathway and are invisible to the more potent EJC-
dependent NMD pathway. As a result, PTC-bearing transcripts of
single-exon genes are more likely to be translated into truncated
protein species with toxic effects. Therefore, it follows that
transcriptional errors creating nonsense codons are likely to be
more deleterious in single-exon than in multi-exon genes. Equally,
in multi-exon genes, the EJC-dependent NMD pathway is thought
to only detect PTCs lying 50–55 nts upstream of the last exon-
exon junction [13]. Consequently, like single-exon genes, last
exons of multi-exon genes are invisible to EJC-dependent NMD in
the mammalian genome and are served only by the PABP-
dependent NMD pathway.
In this study we propose that natural selection has promoted a
dual–strategy of prevention and cure to deal with nonsense errors
in gene expression. Specifically we predict that selection
compensates for the partial efficiency of NMD through a
preventative approach of ‘‘transcriptional robustness’’ that mini-
mizes the consequences of transcriptional error. We investigated
whether human genes eschew codons that can be changed into a
stop codon by one mutation (‘fragile codons’ [14]) in favour of
codons robust to nonsense errors during mistranscription (‘robust
codons’). The standard genetic code comprises 18 fragile codons
and 43 robust codons (Figure 1). Of the 20 amino-acids, six are
encoded exclusively by fragile codons (‘‘fragile amino acids’’), ten
are encoded exclusively by robust codons (‘‘robust amino acids’’)
and four can be encoded by codons of either type (‘‘facultative
amino acids’’). This suggests two distinct mechanisms by which the
transcriptional robustness of a gene can be increased by natural
selection. First, at the level of synonymous codon usage fragile
codons can be avoided when a robust synonym exists. Second, at
the protein level fragile amino-acids can be counterselected.
Using comparisons between single and multi-exon genes
(intergenic) and between different exons of multi-exons genes
(intragenic), we show how each of these mechanisms is used to
increase transcriptional robustness of mammalian genes. Single-
exon genes should provide the clearest signal of transcriptional
robustness and thus provide a ‘‘litmus test’’ of this hypothesis.
Therefore, our first, intergenic, analysis contrasts fragile codon
usage and fragile amino-acid usage in single-exon genes and multi-
exon genes. We performed a second, intragenic, analysis at the
exon-level by taking advantage of the fact that, in mammals, last
exons of multi-exon genes, like single-exon genes, are invisible to
EJC-dependent NMD. Finally, we demonstrate that the two
hallmarks of transcriptional robustness detectable in mammals
(synonymous codon usage and amino-acid usage) can also be
detected in the genes of fission yeast (Schizosaccharomyces pombe)i n
which a mechanistically distinct form of intron-dependent
Nonsense Mediated Decay appears to be active.
Results/Discussion
The inefficiency of NMD in single-exon genes is mitigated
through the mechanism of synonymous codon choice
We used an intergenic comparison to focus initially on the first
mechanism to achieving transcriptional robustness and quantified
it using a normalized fragile codon usage (NFCU) metric. Being
mutational neighbours of STOP codons, the 18 fragile codons are
relatively AT-rich. It is known that GC-content varies along
chromosomes and that these variations in base composition affect
both synonymous codon usage and amino-acid usage. These
variations are particularly strong within mammalian genomes (the
so-called isochore genome organization). To account for both this
compositional bias and the influence of amino acid content, we
used codon usage among facultative amino acids as the basis of the
NFCU metric. NFCU measures the relative usage of fragile and
robust codons among 5 groups of codons where all codons in a
given group (i) have the same GC-content and (ii) are synonymous.
We measured NFCU in 2422 single-exon genes and in 20563
multi-exon genes in the human genome. We observe a 8%
depletion of fragile codons in single-exon genes that is highly
significant (p,10
215, Wilcoxon rank sum test; Table 1). Similarly,
in mouse, measuring NFCU in 3582 single-exon genes and 20263
multi-exon genes reveals a highly significant 11% depletion of
fragile codons in single-exon genes. Both results provide
preliminary support for our hypothesis. We performed a negative
control by repeating the analysis in D.melanogaster in which both
gene sets should on average be equally well served by NMD since
the intron-dependent NMD pathway shows much reduced activity
in fly [2,3]. In the fly genome, the depletion of fragile codons in
single-exon compared to multi-exon genes is almost null (2%)
(Table 1) and, in contrast to human and mouse, can be explained
by transcript length differences (see below).
Notably, repeating the analysis without controlling for amino
acid usage or nucleotide composition but with the benefit of higher
coverage of codons, yields essentially the same result (Text S1,
Result A; Table S1).
The invisibility of histone genes to NMD is mitigated by
synonymous codon choice
Interestingly, one group of genes falls entirely outside of the
range of NMD’s surveillance. Replication-dependent histones
contain neither introns in their coding sequences nor polyA-tail in
their mRNAs [15]. Therefore, histone genes represent a blind-spot
for both mammalian NMD pathways [12]. According to our
hypothesis histone genes should represent the most transcription-
ally robust genes in the mammalian genome since PTC-containing
transcripts of their genes will not be recognized and degraded
before translation. In agreement with this, in human we see that
Author Summary
In biological systems mistakes are made constantly
because the cellular machinery is complex and error-
prone. Mistakes are made in copying DNA for transmission
to offspring (‘‘genetic mutations’’) but are much more
frequent in the day-to-day task of gene expression.
Genetic mutations are heritable and therefore have long
been the almost exclusive focus of evolutionary genetics
research. In contrast, gene expression errors are not
inherited and have tended to be disregarded in evolu-
tionary studies. Here we show how human genes have
evolved a mechanism to reduce the occurrence of a
specific type of gene expression error—transcriptional
errors that create premature STOP codons (so-called
‘‘nonsense errors’’). Nonsense errors are potentially highly
toxic for the cell, so natural selection has evolved a
strategy called Nonsense Mediated Decay (NMD) to ‘‘cure’’
such errors. However this cure is inefficient. Here we
describe how a preventative strategy of ‘‘transcriptional
robustness’’ has evolved to decrease the frequency of
nonsense errors. Moreover, these ‘‘prevention and cure’’
strategies are used interchangeably—the most transcrip-
tionally robust genes are those for which NMD is most
inefficient. Our work implies that gene expression errors
play an important role as supporting actors to genetic
mutations in molecular evolution, particularly in the
evolution of robustness.
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(Table 1) and 26% lower than that of other single-exon genes.
Similarly, in mouse we see that NFCU in histone genes is 53%
lower than that of multi-exon genes (Table 1) and 47% lower than
that of other single-exon genes. Notably, we found that histone
genes in fly show a 30% depletion of NFCU compared to other
single exon genes in accordance with the fact that histone genes
are not served by NMD in fly (Table 1).
The inefficiency of NMD in single-exon genes is also
mitigated through the mechanism of amino-acid choice
The analysis of fragile codon usage controlling for GC and
amino-acid usage (NFCU) shows that the depletion of fragile
codons in human and mouse single-exon genes is not a
consequence of amino acid usage. Therefore, we can ask whether
there is evidence for usage of the second mechanism of
transcriptional robustness by testing whether the amino acid usage
of single-exon gene products reduces the frequency of nonsense
transcriptional errors. Accordingly, we observed that the usage of
fragile amino acids (FAU) among proteins encoded by single-exon
genes is 17% lower than those of multi-exon genes in human and
21% lower in mouse whereas no difference is observed in fly
(Table 2). Therefore the constraints on codon usage in human
genes imposed by the need for transcriptional robustness appear to
be strong enough to influence their amino-acid sequences.
We repeated this analysis to control for GC content differences
between single-exon and multi-exon genes. We used a normalized
fragile amino-acid usage metric (NFAU) that considers the relative
usage of fragile amino-acids among two groups of amino-acids that
are encoded by codons having the same GC-content. Once GC
content is controlled for we observe that the fragile amino acid
content of single-exon gene products is 12% lower than those of
multi-exon genes in human and 16% lower in mouse whereas a
2% enrichment is seen in fly (Table 3).
The correlation between both transcriptional robustness
mechanisms is dependent on selective constraint
Thus far our analysis has demonstrated that, in human and
mouse, single exon genes bear two hallmarks of transcriptional
robustness relative to multi-exon genes (i.e. depletion of fragile
Figure 1. Sense codons differ in their propensity for conversion to STOP codons. The Standard Genetic Code contains 18 fragile codons
(shaded) that can be changed into a STOP codon by a single point-mutation and whose mistranscription can therefore generate nonsense errors. The
remaining 43 sense codons are ‘‘robust’’ to such errors. Six amino acids are encoded exclusively by fragile codons (‘‘fragile amino acids’’, shaded), ten
amino acids are encoded exclusively by robust codons (‘‘robust amino acids’’, unshaded) and four amino acids can be encoded either by robust or
fragile codons (‘‘facultative amino acids’’, hatched shading).
doi:10.1371/journal.pgen.1002276.g001
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mechanisms by which natural selection can prevent nonsense
transcriptional errors: at the level of gene sequence through
synonymous codon choice and at the level of protein sequence
through amino-acid choice. Provisionally, we can attribute this
observation to the inactivity of EJC-dependent NMD in single-
exon genes. However, since all biological processes are inherently
inefficient, EJC-dependent NMD is inevitably also suboptimal.
This raises the question whether there is a genome-wide
requirement for transcriptional robustness. One approach to
answering this question is to ask whether, among all human genes,
there is correlated usage of the two mechanisms (codon-level and
protein-level) to achieving transcriptional robustness.
However, for a given gene the nature of the correlation between
these two mechanisms is likely to depend on the relative level of
constraint on synonymous and non-synonymous sites as measured
by Ka/Ks (the ratio of non-synonymous to synonymous substitu-
tion rates). For the vast majority of human genes, estimates of Ka/
Ks lie in the range 0-1. Broadly, we might expect two different
patterns: (i) For genes with Ka/Ks close to 1, synonymous and
non-synonymous sites are equally modifiable. Therefore, where
nonsense errors are deleterious, natural selection can use both
mechanisms to increase transcriptional robustness (i.e. both fragile
codons and fragile amino-acids can be depleted) leading us to
expect an overall positive correlation between fragile codon usage
and fragile amino-acid usage. (ii) For genes with Ka/Ks close to 0
there is strong selective constraint on the protein sequence and
non-synonymous sites are much less modifiable than synonymous
sites. Here natural selection can use only one mechanism to
increase transcriptional robustness: that of synonymous codon
choice since transcriptional robustness can be less readily increased
through amino-acid choice. Notably, the protein products of many
such genes might be enriched in fragile amino acids due to
functional requirements e.g. proteins involved in signal-transduc-
tion tend to be tyrosine rich and zinc-finger proteins and proteins
enriched in disulfide bonds are cysteine rich. If nonsense errors are
deleterious in such genes then there should be strong counter-
selection of fragile codons to compensate for functionally-
Table 1. Normalized fragile codon content (NFCU) (controlling for GC-content and amino-acid usage) of multi-exon genes and




NMD Genes NFCU P-value Ratio
Human genes
Multi-exon + + 20563 0.47 1.00
(0.41–0.54)
Single-exon: All +/2 2 2422 0.43 ,10
215 0.92
(0.34–0.51)
Non-histone + 2 2367 0.43 ,10
215 0.92
(0.34–0.51)




Multi-exon + + 20263 0.47 1.00
(0.40–0.53)
Single-exon: All +/2 2 3582 0.42 ,10
215 0.89
(0.33–0.51)
Non-histone + 2 3533 0.42 ,10
215 0.89
(0.33–0.51)




Multi-exon + 2 11643 0.54 1.00
(0.48–0.60)
Single-exon: All +/2 2 2498 0.53 0.0002 0.98
(0.45–0.62)
Non-histone + 2 2466 0.53 0.002 0.98
(0.45–0.62)
Histone 2 2 32 0.38 ,10
29 0.69
(0.38–0.38)
Single-exon genes were first treated as a single group to determine the impact of EJC-dependent NMD on fragile codon content and subsequently subdivided into
histone and non-histone genes to consider the impact of PABP-dependent NMD on fragile codon content. NFCU, median (first and third quartiles) of fragile codon
content normalized for GC-content and amino acid usage; P-value, significance of the comparison with multi-exon genes determined by two-sided Wilcoxon-rank sum
test that tests for a linear shift in distribution locations; Ratio, median NFCU relative to the median NFCU for multi-exon genes.
doi:10.1371/journal.pgen.1002276.t001
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selective constraint at the amino-acid level we would therefore
expect an overall negative correlation between fragile codon usage
and fragile amino-acid usage. Among genes with strong selective
constraint on protein sequence, the magnitude of this negative
correlation is likely to depend on the abundance of genes with
functions requiring high fragile amino-acid content.
Considering all human genes (single-exon and multi-exon genes)
we see a positive correlation between both transcriptional
robustness mechanisms (Spearman correlation for NFCU versus
NFAU: rho=0.06, n=22985, p,10
215). More specifically, for
human genes having mouse orthologs we can determine how this
correlation depends on the strength of selective constraint. We
observe that the sign and magnitude of the correlation between





NMD Genes FAU P-value Ratio
Human genes
Multi-exon + + 20573 0.23 1.00
(0.20–0.27)




Multi-exon + + 20284 0.24 1.00
(0.21–0.27)




Multi-exon + 2 11643 0.23 1.00
(0.20–0.26)
Single-exon: +/2 2 2498 0.23 0.97 1.00
(0.20–0.26)
FAU, median (first and third quartiles) of fragile amino acid content of encoded proteins; P-value, significance of the comparison with multi-exon genes determined by
two-sided Wilcoxon-rank sum test that tests for a linear shift in distribution locations; Ratio, median FAU relative to the median FAU for multi-exon genes.
doi:10.1371/journal.pgen.1002276.t002
Table 3. Normalized fragile amino acid usage (NFAU) (controlling for GC-content) of proteins encoded by multi-exon genes and




NMD Genes NFAU P-value Ratio
Human genes
Multi-exon + + 20573 0.44 1.00
(0.39 – 0.48)




Multi-exon + + 20284 0.43 1.00
(0.39 – 0.48)




Multi-exon + 2 11643 0.41 1.00
(0.37 – 0.46)
Single-exon +/2 2 2498 0.42 ,10
24 1.02
(0.37 – 0.48)
NFAU, median (first and third quartiles) of normalized fragile amino acid content of encoded proteins; P-value, significance of the comparison with multi-exon genes
determined by two-sided Wilcoxon-rank sum test that tests for a linear shift in distribution locations; Ratio, median NFAU relative to the median NFAU for multi-exon
genes.
doi:10.1371/journal.pgen.1002276.t003
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protein-level) is dependent on the strength of selective constraint
on protein sequence in agreement with our prediction (Figure 2).
First, for genes towards the upper end of the Ka/Ks range, our
first prediction holds. Thus among genes under weaker selective
constraint at the protein level (mean Ka/Ks for the fourth quartile
of selective constraint = 0.38), we observe a positive correlation
between normalized fragile codon usage (NFCU) and normalized
fragile amino-acid usage (NFAU) (Figure 2). In other words, for
genes in which non-synonymous sites are, on average, only 60%
less modifiable than synonymous sites, both transcriptional
robustness mechanisms are available to selection. Moreover, it is
striking that among the top three quartiles of Ka/Ks the positive
correlation between both mechanisms increases in magnitude with
weakening selective constraint (Spearman’s rho (p-values) for
NFCU versus NFAU in Ka/Ks quartiles 2-4: 0.050 (p=0.001);
0.068 (p,10
25); 0.076 (p,10
26)). Therefore with increasing
‘flexibility’ of the protein sequence there is an increasing tendency
for transcriptional robustness to be realized not only through
synonymous codon choice but also through amino-acid choice.
However, for genes under strong selective constraint at the
protein level (mean Ka/Ks for the first quartile of selective
constraint = 0.03) the correlation between transcriptional
robustness mechanisms is negative (Spearman’s rho for NFCU
versus NFAU in Ka/Ks quartile 1: -0.025 (p=0.09); Figure 2). For
such genes non-synonymous sites are, on average, 97% less
modifiable than synonymous sites and a requirement for
transcriptional robustness can only be accommodated at the level
of synonymous codon usage and not at the level of amino-acid
usage.
In summary, the fact that the genome-wide correlation between
usage of fragile codons and fragile amino-acids depends on
selective constraint points to a universal requirement for
transcriptional robustness to nonsense errors among human genes.
The absence of splicing constraints cannot explain the
lower fragile codon content of single-exon genes
A simple interpretation of the lower fragile codon content of
single-exon genes is that this observation may be due to differences
in splicing-related constraints between single and multi-exon
genes. Splicing requires regulatory sequences located in exons
known as exonic splicing enhancers (ESEs). Since these hexamer
sequences overlap codons, their presence imposes additional
constraints on the coding sequence of multi-exon genes [16] in
contrast to the coding sequence of single-exon genes that have no
such splicing constraints. Therefore, if the nucleotide composition
of ESEs is such that they tend to encode fragile codons then a
simple difference in ESE density between single and multi-exon
genes could provide a trivial explanation for the relative
enrichment of fragile codons in the latter group.
We found that ESEs indeed tend to encode fragile codons and
that ESEs are depleted in single-exon genes. However the
difference in fragile codon usage between single and multi-exon
genes persists when this is controlled for showing that our
Figure 2. The genome-wide correlation between transcriptional robustness strategies depends on selective constraint. Pairwise
correlation between normalized fragile codon usage (NFCU) and normalized fragile amino-acid usage (NFAU) for 17421 human genes with an
ortholog in mouse. Human genes were binned by selective constraint (Ka/Ks) estimated using the pairwise alignment with their mouse ortholog and
for each quartile of Ka/Ks (Q1, lowest, to Q4, highest), Spearman’s correlation between normalized fragile codon usage and normalized fragile amino-
acid usage (rNFCU.NFAU) was calculated. The vertical extent of the bar indicates the 95% confidence interval for each correlation.
doi:10.1371/journal.pgen.1002276.g002
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constraints (Text S1, Result B; Figure S1).
The lower fragile codon content of single-exon genes
cannot be explained by selection for translationally
optimal codons
The patterns of fragile codon usage in single-exon and multi-
exon genes could be due to a more familiar source of codon usage
bias that has nothing to do with their propensity for nonsense
errors. In fly, selection for translational efficiency or accuracy leads
to the preferential usage of optimal codons in highly expressed
genes [17]. Moreover, recent evidence suggests that such selection
might also operate on mammalian genes [18–20]. The possible
influence of selection for translational efficiency raises two
potential concerns for our analysis. First, in human, it might
create an artifactual difference in fragile codon usage of the
magnitude we observe between single and multi-exon genes
leading us to falsely infer a difference in transcriptional robustness
between these gene sets. Second, in fly, it might obscure a real
difference in transcriptional robustness by homogenizing fragile
codon usage between single and multi-exon genes and therefore
might invalidate the use of the Drosophila genome as a negative
control.
Among codons we see no association in either human or fly
between fragility with respect to nonsense errors and translational
optimality (see Text S1, Result C). Nevertheless, to account for the
possibility that there is an association among genes between
transcriptional robustness and selection for translational accuracy
we repeated the analysis of fragile codon content in human and fly
and controlled for the fraction of optimal codons per gene (Fop)
[17,21].
Comparing human single and multi-exon genes binned in this
way revealed that the difference in both FCU and NFCU persists
independently of their optimal codon usage (see Text S1, Result C;
Figure S2). Thus in human, the difference in fragile codon usage
between single and multi-exon genes is not an artifact of selection
for translationally optimal codon use. Additionally, in fly, the
control for optimal codon usage has no influence on the
magnitude of the difference between single and multi-exon genes
with respect to either FCU or NFCU (see Text S1, Result C;
Figure S3). Thus in fly, selection for translationally optimal codons
does not mute any signal for transcriptional robustness among
single-exon genes.
Intragenic comparison shows that fragile codons are
depleted in last exons of human multi-exon genes
The fact that only PTCs lying more than ,50–55 nts upstream
of the last Exon Junction Complex (EJC) are thought to be
detected by the EJC-dependent NMD pathway suggests that,
similarly to single-exon genes, last exons of multi-exon genes
constitute a blind-spot for EJC-dependent NMD and are served
only by PABP-dependent NMD. Although a mechanism for
detection of PTCs downstream of the last EJC has been described
(‘‘fail-safe’’ NMD), its activity is believed to be restricted to
exceptional targets [22]. We therefore hypothesized that last exons
of multi-exon genes should show a depletion of fragile codons
comparable to that seen in single-exon genes.
For human multi-exon genes whose coding sequence is
completely contained within the last exon we see a significant
8% depletion of fragile codons compared to multi-exon genes
having at least two coding exons (see Text S1, Result D). We next
used an intragenic comparison to ask whether the last exons of all
human multi-exon genes show a similar depletion of fragile
codons. To address this we performed an exon-based analysis of
human multi-exon genes that have a reliably annotated last exon
and at least one upstream coding exon. We created one group of
last exons and one group of upstream exons and compared these
with respect to NFCU. We found that fragile codons exhibited a
significant (p=0.0002, Wilcoxon rank-sum test) 7% depletion
among last exons (n=12390, median NFCU=0.47) compared to
upstream exons (n=112789, median NFCU=0.50) (Table 4). We
repeated the analysis in mouse and observed a 8% depletion of
fragile codons (p=0.002, Wilcoxon rank-sum test) among last
exons (n=13265, median NFCU=0.46) compared to upstream
exons (n=132678, median NFCU=0.50). As a control we
performed the same analysis on Drosophila multi-exon genes in
which NMD should be equally efficient in upstream and last
exons. In accordance with our expectation we saw no depletion of
fragile codons among last exons (n=6304, median NFCU=0.53)
compared to upstream exons (n=25686, median NFCU=0.53) of
Drosophila multi-exon genes.
These results were confirmed by an analysis based on matching
the last exon of each human multi-exon gene with the upstream
sequence of the same gene. There are 12324 human multi-exon
genes with reliably annotated last exons and for which NFCU is
defined in both the last exon and in the upstream sequence.
Among the 12265 genes for which NFCU differs between these
two regions, for 6599 (54%) fragile codon content is lower in the
last exon than in the upstream sequence whereas in 5666 genes
NFCU in the last exon is greater than in the upstream sequence
(p,10
216, binomial test). Considering NFCU for all 12324 pairs of
upstream and last exons showed that their fragile codon content is
significantly different (p,10
215, Wilcoxon signed-rank test).
Notably, we found that the depletion of fragile codons in last
exons of human multi-exon genes can not be explained by the
different splicing requirements for the final exon of transcripts [23]
(see Text S1, Result E).
Intragenic depletion of fragile codons commences
beyond the boundary of EJC–dependent NMD activity
The depletion of fragile codons in last exons is particularly
striking given the fact that a reduction in the selective costs of
premature peptide truncation in last exons might mute any signal
of transcriptional robustness caused by inefficient NMD in these
exons. In other words, if NMD was equally efficient in upstream
and last exons we would expect fragile codons to be enriched in
last exons because PTCs generated by mistranscription in last
exons are, on average, closer to the normal termination codon
(NTC). If these PTCs remain undetected by NMD, the resultant
short peptide truncations should have trivial fitness consequences
compared to longer peptide truncations caused by undetected
PTCs in upstream exons. Consistent with this, the fragile codon
content of last exons of human multi-exon genes (median
NFCU=0.47) is greater than that of human single-exon genes
(median NFCU=0.43) despite the fact that both are invisible to
EJC-mediated NMD.
We attempted to control for the effect of trivial peptide
truncation by analyzing NFCU in regions on either side of the
boundary of EJC-dependent NMD but located at least 50 codons
away from the normal termination codon. We focused on multi-
exon genes having reliably annotated last exons longer than 100
codons and having at least 50 codons in the NMD-competent
region of upstream exons (Figure 3). Specifically, for each multi-
exon gene we calculated NFCU in a 39 window comprising the
first 50 codons encoded by the last exon and contrasted this with
NFCU calculated from a neighbouring 50-codon 59 window
ending 50 nts upstream of the last exon-exon junction. For human
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region (invisible to EJC-dependent NMD) and the 59 window lies
in the NMD-competent region (visible to EJC-dependent NMD).
The boundary between NMD-competent and NMD-compro-
mised regions of human multi-exon genes is described as lying 50–
55 nts upstream of the last exon-exon junction (the ‘‘50- to 55- nts
rule’’) but the universality of this rule is unclear in the light of more
recent genome-wide observations [24] and individual gene studies
[25]. Consequently, the parameter settings for positioning these
windows were chosen to reflect the uncertainty in the position of
this boundary.
In this analysis we saw a 10% reduction in fragile codon density
in 39 (NMD-compromised) windows compared to 59 (NMD-
competent) windows (n=2616; 59 windows, median NFCU=
0.50; 39 windows, median NFCU=0.45; p=0.016, Wilcoxon
rank-sum test). As a negative control we repeated this analysis on
Drosophila multi-exon genes in which EJC-dependent NMD shows
reduced activity implying that surveillance of nonsense errors
should be equally efficient in the 59 and 39 windows. As expected
we saw no difference in fragile codon density between these
window sets (n=2420; 59 windows, median NFCU=0.5; 39
windows, median NFCU=0.5; p=0.199, Wilcoxon rank-sum
test).
We repeated this test to account for the reduced density of ESEs
in human last exons by partitioning the codons in each window
into those that overlap ESEs and those external to ESEs and then
recalculating NFCU. Both analyses qualitatively agreed with the
full analysis considering all 50 codons in each window (data not
shown).
In summary, we see a consistent pattern of depletion of fragile
codons in the last exons of human multi-exon genes when
compared with upstream exons. This accords with their status as
NMD-compromised regions that are invisible to EJC-dependent
NMD and visible only to the PABP-dependent NMD pathway.
The selective pressure to avoid fragile codons in last exons
imposed by the requirement for transcriptional robustness is likely
to be partly offset by increased tolerance of PTCs lying close to the
NTC. Nevertheless, transcriptional robustness appears to be an
important determinant of codon choice in the last exons of human
multi-exon genes as well as in single-exon genes.
Depletion of fragile codons is due primarily to inactivity
of EJC–dependent NMD but also to reduced efficiency of
PABP–dependent NMD
Since transcriptional robustness is likely to be a consequence of
reduced NMD potency we can attempt to dissect the relative
contributions to this phenomenon of each of the two mammalian
NMD pathways. The large depletion of fragile codons in histone
genes relative to other single-exon genes (Table 1) suggests that
much of the variation in transcriptional robustness among and
within human genes might be explained by variation in the
efficiency of PABP-dependent NMD. Notably, the ability of this
pathway to detect PTCs increases with the distance between the
PTC and the polyA-binding protein (PABP) [1]. Single-exon genes
produce shorter mRNAs than multi-exon genes (the coding
sequences (CDS) of human single-exon genes and multi-exon
genes have a median length of 534 nts and 1203 nts, respectively).
Multi-exon genes may therefore be subject to more potent NMD
than single-exon genes owing simply to more efficient surveillance
by the PABP-dependent NMD pathway. This follows from the fact
that, in multi-exon genes, any PTCs formed by mistranscription
will be, on average, more distant from the PABP and thus will
elicit PABP-dependent NMD more efficiently.
We investigated whether decreased efficiency of PABP-depen-
dent NMD alone is responsible for the greater transcriptional
robustness of single-exon genes due to the shorter length of their
transcripts. We compared NFCU between single and multi-exon
genes binned by CDS length (Figure 4) and found that NFCU was
significantly lower in single exon genes than in multi-exon genes for





NMD Exons NFCU P-value Ratio
Human multi-exon genes
Upstream exons + + 112789 0.50 1.00
(0.39 – 0.48)
Last exons + 2 12390 0.47 0.0002 0.93
(0.29 – 0.61)
Mouse multi-exon genes
Upstream exons + + 132678 0.50 1.00
(0.26 – 0.67)
Last exons + 2 13265 0.46 0.002 0.92
(0.30 – 0.60)
Fly multi-exon genes
Upstream exons + 2 25686 0.53 1.00
(0.41 – 0.67)
Last exons + 2 6304 0.53 0.21 1.00
(0.41 – 0.67)
NFCU, median (first and third quartiles) of fragile codon content normalized for GC-content and amino acid usage; P-value, significance of the comparison of upstream
and last exons determined by two-sided Wilcoxon-rank sum test that tests for a linear shift in distribution locations; Ratio, median NFCU relative to the median NFCU for
upstream exons.
doi:10.1371/journal.pgen.1002276.t004
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Wilcoxon-rank sum test) of median NFCU in single-exon genes
relative to median NFCU in multi-exon genes for length bins Q1-
Q4 are 0.92 (p,10
215), 0.90 (p,10
215), 0.97 (p=0.03), 0.99
(p=0.91), respectively. Thus only the longest single-exon transcripts
have fragile codon content equal to that of multi-exon transcripts of
similar length. This result suggests that the increased transcriptional
robustness of single-exon genes is primarily due to the lack of
supplementary nonsense surveillance from EJC-dependent NMD.
However, the longest single-exon transcripts also benefit from an
increase in the efficiency of PABP-dependent NMD.
Repeating this procedure in our analysis of fly genes revealed no
difference in NFCU between single-exon and multi-exon genes
when length differences are controlled for (data not shown). Thus
the modest 2% depletion of fragile codons seen in fly single-exon
genes compared to multi-exon genes is entirely due to the
inefficiency of PABP-dependent NMD of shorter transcripts
(Table 1).
Transcriptional robustness is also a property of genes
that are invisible to splicing-dependent NMD in fission
yeast
It has recently been demonstrated that splicing enhances NMD
in Schizosaccharomyces pombe in a manner apparently independent of
the EJC [26]. This organism provides us with an independent test
of our hypothesis in a system of splicing-dependent NMD that is
mechanistically distinct from that in mammals. We measured
NFCU in S.pombe genes and found that single-exon genes (median
NFCU=0.43) show a highly significant (p,10
215; Wilcoxon-rank
sum test) 6% depletion of fragile codons relative to multi-exon
genes (median NFCU=0.46) echoing our observations in human
and mouse. However, in contrast to the situation in mammals and
fly, the CDS of single-exon genes is longer than that of multi-exon
genes in S.pombe (the coding sequence (CDS) of S.pombe single-exon
genes and multi-exon genes have a median length of 1220 nts and
1053 nts, respectively). Therefore we tested for the possibility that
the signal of robustness in single-exon genes in S.pombe is muted by
the reduced efficiency of PABP-dependent NMD in the shorter
mRNAs of multi-exon genes. We compared single and multi-exon
genes in bins of equal CDS length and found that fragile codons
are significantly depleted in single-exon genes for all length bins
except the shortest: the ratios (p-values; Wilcoxon-rank sum test) of
median NFCU in single-exon genes relative to median NFCU in





The signal associated with the second mechanism of transcrip-
tional robustness (amino-acid choice) is less strong in S.pombe.
Among fission yeast proteins we observe a 3% depletion (p,10
214;
Figure 3. Intragenic depletion of fragile codons commences beyond the boundary of EJC–dependent NMD activity. Normalized
fragile codon usage (NFCU) in ‘‘NMD-competent’’ and ‘‘NMD-compromised’’ regions of multi-exon genes. The schematic depicts a generic
mammalian mature mRNA. The arrowhead shows the position of the last exon-exon junction. The relative efficiency of each mammalian NMD
pathway predicted in three distinct regions is shown using ‘+’ symbols. Predicted inactivity of NMD is shown using a ‘-’ symbol. EJC-dependent NMD
is expected to be active .50–55 nts 59 of the last exon-exon junction and inactive 39 of the last exon-exon junction. Its activity is uncertain in the
intervening 50–55 nts region (hatched shading). PABP-dependent NMD is expected to increase in efficiency with distance from the poly-A tail. Note
that the efficiency of PABP-dependent NMD is predicted to be much lower than that of EJC-dependent NMD. NFCU was determined in two windows
of 50 codons positioned on either side of the last exon-exon junction. The example shows the last intron in ‘‘phase 0’’ (i.e. the intron is positioned
between codons) and the depicted nucleotide coordinates for each window are specific to this case.
doi:10.1371/journal.pgen.1002276.g003
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products of single-exon genes (median NFAU=0.397) compared
to multi-exon gene products (median NFAU=0.410).
Conclusion
In this study we set out to investigate whether human genes
have evolved ‘‘transcriptional robustness’’ to reduce the frequency
of mistranscription events leading to nonsense errors. More
specifically we hypothesized that such a strategy of nonsense
prevention should complement the cure for nonsense errors
provided by Nonsense Mediated Decay (NMD). Indeed by
comparing single-exon genes (in which NMD is inefficient) and
multi-exon genes (in which NMD is much more efficient) we show
that intergenic variation in transcriptional robustness reflects
intergenic differences in NMD efficiency. Specifically, the primary
hallmark of this robustness is a depletion of ‘‘fragile’’ codons that
are susceptible to mistranscription into a STOP codon. We took
account of differences between single-exon and multi-exon genes
that, although unrelated to transcriptional robustness, might
nevertheless covary with fragile codon usage. Our result is not
explained by biologically confounding variables such as differences
in splicing constraints or transcription associated mutational biases
(see Text S1, Result F) nor by possible technical biases due to gene
annotation issues or phylogenetic dependencies (see Text S1,
Result G). Having excluded these alternatives we can conclude
that, in human, there is a real difference in transcriptional
robustness of single-exon and multi-exon genes.
Is there an alternative explanation for intergenic variation in
transcriptional robustness that is unrelated to the efficiency of
NMD? Before attributing our observation to intergenic differences
in NMD efficiency, other differences between single-exon and
multi-exon genes that could promote robustness need to be
considered. Notably our intergenic analysis makes two assump-
tions: all genes have (i) equal transcriptional error rates and (ii)
similar selective costs associated with the toxic effects of truncated
proteins. However, if either of these quantities was, on average,
greater in single-exon genes than in multi-exon genes then this
would promote increased transcriptional robustness of single-exon
genes even if NMD were equally potent in both groups.
Our analysis of intragenic patterns of fragile codon use
addresses both assumptions, by isolating the influence on
transcriptional robustness of variable NMD efficiency from the
influences of variable transcriptional fidelity and selective costs of
nonsense errors. First, although transcriptional fidelity might vary
between genes, it is not likely to vary within genes. In contrast, the
efficiency of NMD varies not only between genes but also within
genes since, like single-exon genes, last exons of multi-exon genes
are invisible to EJC-dependent NMD in mammals. Therefore if
Figure 4. Fragile codon depletion is not due to reduced efficiency of PABP–dependent NMD in shorter mRNAs. Normalized fragile
codon usage (NFCU) of human single- (S) and multi-exon (M) genes binned by transcript CDS length. For each quartile of transcript length (Q1,
shortest, to Q4, longest) NFCU for single and multi-exon genes is plotted separately. The width of each bin is proportional to the square root of the
number of genes it contains.
doi:10.1371/journal.pgen.1002276.g004
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tional fidelity then this could explain the intergenic but not the
intragenic patterns of fragile codon use that we see (i.e. depletion
of fragile codons in last exons). Second, although the selective costs
of nonsense errors might vary within genes this should result in an
enrichment of fragile codons in last exons rather than the
depletion observed.
Therefore the intragenic pattern of fragile codon usage in
mammalian genes, and in particular the depletion of fragile
codons in last exons, suggests that variable NMD-efficiency
underlies transcriptional robustness. Although these patterns do
not implicate variation in transcriptional fidelity or in the selective
costs of undetected nonsense errors as unique explanations of
transcriptional robustness these factors might also contribute to
intergenic differences in robustness. Importantly, the result of our
intragenic analysis strongly suggests that constraints on codon
usage imposed by the requirement for transcriptional robustness
are common to all mammalian genes and are not peculiar to the
minority of genes that are intronless in mammals (,11% and
,15% of genes in the human and mouse genomes, respectively).
We conclude therefore, that natural selection has promoted a
dual strategy of ‘‘prevention and cure’’ to deal with the problem of
nonsense transcriptional errors and that these strategies are used
interchangeably in mammals. This example of complementarity
between strategies for error-prevention and error-mitigation in
mammals echoes the recent demonstration in bacteria of
complementarity between cis and trans strategies in limiting protein
misfolding [27].
There is evidence that both the intron content [5] and the exon-
intron structure [24,28,29] of human genes are shaped by the
general mode of action and specific spatial requirements of NMD.
We show that variable NMD efficiency also leaves its signature in
the coding sequences of human genes and in the amino-acid
content of the proteins they encode. This signature can be
discerned in patterns of codon choice and amino-acid usage in
single-exon genes that together constitute two hallmarks of
transcriptional robustness. It is also evident in codon usage in
the last exons of multi-exon genes and thus constrains a substantial
fraction of sites in human genes. We suggest that fragile codons are
counterselected in human genes not because they pose a potential
future mutational hazard but because of the immediate hazard
associated with undetected nonsense errors during their transcrip-
tion. However, a notable side-effect of transcriptional robustness is
the creation of a ‘‘congruent robustness’’ [30] to future nonsense-
creating genetic mutations. The negative selection invoked here is
mediated by transcriptional errors and not by genetic mutations.
Indeed, transcriptional errors, together with splicing and transla-
tion errors, may exert a negative effect on fitness despite the
presence of a normal genotype. Such errors in gene expression
[31,32] may play a much more prominent role in molecular
evolution than is currently recognized [33]. One such role may be
to expose subtle fitness differences between otherwise equally-fit
genotypes, enabling positive selection to explore sequence space in
the vicinity of a given genotype by means of a so-called ‘‘look-
ahead effect’’ [33]. Equally, we suggest, the evolutionary foresight
gained from this effect may reveal pitfalls in sequence space and
enable negative selection to purge genotypes that lie close to these
pitfalls by providing a preview of their deleterious consequences.
This effect provides a rationale for the promotion of robustness by
natural selection even when the population genetic conditions of
high genetic mutation rate and large effective population size,
conventionally thought to be necessary for the evolution of
robustness [34], are not met. Together with the identification of
robustness to translational errors [18] and to splicing errors [5],
this study underscores the importance in molecular evolution of
the full spectrum of errors made in the decoding of phenotype
from genotype. Moreover, the patterns of fragile codon usage and
fragile amino-acid usage described for human genes suggest that
transcriptional errors are frequent and can be highly deleterious.
This raises the question of the past and present impact of such
errors on human disease.
Materials and Methods
Datasets
We used Ensembl release 49 gene annotations for human and
mouse and Flybase release 5.4 for Drosophila annotations [35].
For each gene prediction we retrieved its CDS from Ensembl. In
the case of multiple alternative transcript predictions, we
retained the transcript encoding the longest peptide and used
the total number of annotated coding and non-coding exons in
the transcript as the exon count for that gene. A dataset of
histone genes was constructed by retrieving 72 Genbank
accessions for human histone genes from [15] and mapping
these to unique Ensembl gene identifiers using the BioMart tool.
Fly orthologs of human histone genes were retrieved using
BioMart. We constructed a dataset of exonic splicing enhancers
(ESEs) consisting of 443 hexamer sequences by merging human
and mouse ESEs determined using the RESCUE-ESE approach
[36-38].
Fragile codon usage (FCU)
We defined two categories of codons using a classification
introduced by [14] : ‘‘fragile codons’’ are defined as sense codons
that can be converted into a STOP codon by a single point-
mutation whereas all other sense codons are defined as ‘‘robust’’
(Figure 1). The fragile codon usage (FCU) metric considers all 61
sense codons and was calculated by enumerating all fragile and
robust codons and expressing fragile codon density (FCU) as the
fraction of all sense codons that are fragile for each gene.
Normalized fragile codon usage (NFCU)
Normalized fragile codon usage (NFCU) was calculated by
considering only groups of codons that are synonymous and have
equal GC content but differ with respect to their fragility. These
groups were chosen from among codons encoding ‘‘facultative
amino acids’’ (Figure 1). Four such groups have two-members
that are respectively fragile and robust: TCA, TCT (encoding
Serine; 1/3 nts are G or C), TCG, TCC (encoding Serine; 2/3
nts are G or C), CGA, CGT (encoding Arginine; 2/3 nts are G or
C) and GGA, GGT (encoding Glycine; 2/3 nts are G or C). A
fifth, three membered, group encodes Lysine and consists of
TTG, CTT and CTA (fragile, robust and robust codons
respectively; 1/3 nts are G or C). For each CDS we computed
the fractional fragile codon usage for each of these five
synonymous groups (number of fragile codons/the total number
of codons in the group). Finally, for each gene we expressed the
normalized fragile codon usage (NFCU) of its CDS as the average
of all fractions that are defined (i.e. that have a denominator
greater than zero).
Fragile amino-acid usage (FAU)
For each gene we considered its encoded peptide (using the
longest in the case of alternative isoforms) and calculated the
fraction of all amino acids that are fragile (Cys, Gln, Glu, Lys, Trp,
Tyr) (Figure 1) considering all amino-acids for each protein (i.e.
FAU = count of fragile amino-acids/total count of amino-acids).
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Normalized fragile amino-acid usage (NFAU) was calculated by
considering only groups of amino-acids that are encoded by
codons of equal GC content. For each gene we considered its
longest encoded peptide and, for two separate groups of amino-
acids, calculated the fraction of amino-acids that are fragile. The
first group consists of four amino-acids encoded by codons for
which 1/6 nts are G or C: Tyr (fragile), Lys (fragile), Asn (robust)
and Phe (robust). The second group consists of eight amino-acids
encoded by codons for which 1/2 nts are G or C: Gln (fragile), Glu
(fragile), Cys (fragile), Ser (facultative), His (robust), Thr (robust),
Val (robust), Asp (robust). For each protein we computed the
fractional fragile amino-acid usage for each of these two groups
(count of fragile amino-acids/total count of amino-acids in the
group). Finally, for each protein we expressed the normalized
fragile amino-acid usage (NFAU) as the average of defined
fractions.
Correlation between transcriptional robustness strategies
Human-mouse orthologs were retrieved using the BioMart tool.
In the case of human genes having multiple co-orthologs we
retained the longest mouse ortholog (choosing a random protein in
the case of length ties). We aligned human-mouse orthologous
pairs using CLUSTALW [39] and, using the corresponding CDS,
back-translated each alignment to create a codon-based align-
ment. These alignments were used as input for the yn00 program
in the PAML package [40] to estimate Ka/Ks i.e. the ratio of non-
synonymous substitutions per non-synonymous site (Ka)t o
synonymous substitutions per synonymous site (Ks). Four groups
of human genes of similar selective constraint were constructed
based on quartiles of Ka/Ks for all human-mouse orthologs. For
each group we calculated the Spearman correlation between
normalized fragile codons usage (NFCU) and fragile amino-acid
usage (NFAU) metrics.
Exon-based analysis
We performed an exon-based analysis to compare NFCU in last
exons and upstream exons. We considered only genes for which
we could be sure that the annotated last exon is the true last exon.
Last exons were considered as reliably annotated if they (i) have a
CDS sequence that terminates with a STOP codon, (ii) do not
have a downstream non-coding exon (and therefore do not have a
downstream EJC) and (iii) have an annotated 39 UTR of at least
100 nts. For each gene having a reliably annotated last exon we
assigned the last exon to one group and each remaining exon to a
second group (‘‘upstream exons’’). We calculated NFCU for each
exon using only those codons completely encoded by the exon and
compared NFCU in the ‘‘last exon’’ and ‘‘upstream exon’’ groups.
Determining phylogenetic independence of histone
genes
Using the dataset of histone genes retrieved from Ensembl as
described above we constructed sequence alignments between all
pairs of histone proteins using CLUSTALW [39] and, using the
corresponding CDS, back-translated each alignment to create a
codon-based alignment. These alignments were used as input for
the yn00 program in the PAML package [40] and pairwise
sequence divergence was determined by calculating synonymous
site divergence (Ks).
Supporting Information
Figure S1 The absence of splicing constraints cannot explain the
lower fragile codon content of single-exon genes. Normalized
fragile codon usage (NFCU) of human single- (S) and multi-exon
(M) genes binned by ESE density within the CDS. For each
quartile of ESE density (Q1, lowest, to Q4, highest), NFCU for
single and multi-exon genes is plotted separately. The width of
each bin is proportional to the square root of the number of genes
it contains.
(TIF)
Figure S2 Fragile codon usage patterns among human genes are
not due to selection for translational accuracy. Normalized fragile
codon usage (NFCU) of human single- (S) and multi-exon (M)
genes binned by the fraction of translationally optimal codons per
gene controlling for GC content (FopGC). For each quartile of
FopGC (Q1, lowest, to Q4, highest), NFCU for single and multi-
exon genes is plotted separately. The width of each bin is
proportional to the square root of the number of genes it contains.
(TIF)
Figure S3 Fragile codon usage patterns among fly genes are not
due to selection for translational accuracy. Normalized fragile
codon usage (NFCU) of Drosophila single- (S) and multi-exon (M)
genes binned by the fraction of translationally optimal codons per
gene (Fop). For each quartile of Fop (Q1, lowest, to Q4, highest),
NFCU for single and multi-exon genes is plotted separately. The
width of each bin is proportional to the square root of the number
of genes it contains.
(TIF)
Table S1 Fragile codon usage (FCU) of multi-exon genes and
single-exon genes in the human, mouse, and fly genomes.
(DOC)
Text S1 Supporting results.
(DOC)
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